What You Should Know:
- Tavros Therapeutics, a precision oncology platform company leading the new frontier of targeted therapies exploiting tumors’ genetic vulnerabilities raises $7.5 million in Seed II financing co-led by existing investor Piedmont Capital Investments and new investor KdT Ventures, with participation from Alexandria Venture Investments.
- Tavros launched in 2020 with a $3 million seed financing by Piedmont Capital Investments and a strategic collaboration with Zentalis
Read More
Oncology Technology Solutions, Services Impacting Patients and Providers
Caris Life Sciences Integrates with Flatiron Health for Molecular Testing
What You Should Know:
- Caris Life Sciences, the leading molecular science and technology company, announced their partnership with Flatiron Health to fully integrate Caris’ molecular testing portfolio with Flatiron’s OncoEMR®, a cloud-based electronic medical record (EMR) tool.
- This partnership streamlines clinical workflows for physicians, delivering critical results directly at the point of care to help them make better treatment decisions for their patients.
Molecular
Read More
Naveris Raises $51M for Early Detection of Viral-Driven Cancers
What You Should Know:
- Naveris, Inc., a commercial-stage life sciences company dedicated to improving patient care through earlier detection of viral-driven cancers, recently announced a $33.4M expansion of its Series A financing, bringing the total investment in Naveris to $51M.
- The financing was led by Gurnet Point Capital, joined by TechU Ventures and BrightEdge, the impact and venture capital arm of the American Cancer Society.
Using DNA Fragmentomics Technology to Detect
Read More
Children’s Oncology Group Taps Tempus to Provide Genomic Sequencing for Pediatric Cancer Patients
What You Should Know:
-Tempus, an $8B precision medicine company, is providing genomic sequencing for 300 eligible pediatric cancer patients annually through their new collaboration with the Children’s Oncology Group (COG). Tempus’ support for COG – a leader in pediatric oncology research – will assist with matching patients to clinical trials like the Pediatric MATCH Screening Trial APEC1621SC (NCT03155620), which is studying the effectiveness of genetic testing-directed treatment in
Read More
Enzee Health Nabs $1.5M for Cloud-Based Compliance Management Platform
What You Should Know:
- Enzee Health, formerly ZapIT! Medical is announcing it has secured $1.5M in seed financing, led by Rev1 Ventures with participation from Tamarind Hill, Harbor Street Ventures, M7 NEO, Redgrave Investments, Service Provider Capital and others.
- Enzee empowers hospital personnel to easily perform and track required quality testing within departments, eliminating the inefficiencies of paper record keeping, and making it easier for administrators to assess whether
Read More
The Fast Pace of Cancer Research is Leaving Community Clinicians Behind
We are witnessing an accelerated pace of amazing breakthroughs and advancements in cancer care today, with new treatments emerging almost weekly and unprecedented opportunities to help improve patient outcomes every day. However, if a doctor is not working in an academic setting, reading every new paper, and recruiting patients for new studies, how can they be expected to keep up with the latest treatments and approaches to specific cancers? When
Read More
Ypsomed & Sidekick Health Partner to Improve Therapy Outcomes
What You Should Know:
- Ypsomed and Sidekick Health today announced a collaboration to extend Ypsomed’s device and SmartServices offering by implementing a self-injection module in Sidekick’s proven digital therapeutics solution.
- The combination of Ypsomed’s devices with Sidekick’s digital health, behavioural economics and gamification expertise will form a unique solution delivering an engaging and personalized patient experience to people with chronic conditions, as well as a turn-key,
Read More
Pharmacogenomics: The Key to Unlocking the Future of Personalized Healthcare
Pharmacogenomics—the study of genetic influences on an individual's response to therapeutic medications—is an area of personalized medicine that is gaining momentum. Although pharmacogenomics has been around for a while, providers, health plans, pharmacists and legislators are developing a greater appreciation for its potential benefits and applications.
How Can Pharmacogenomics Improve Outcomes?
By considering a person’s DNA in treatment options, providers can determine how an
Read More
Syapse and Genesis Research Form RWE Partnership in Oncology
What You Should Know:
- Today, Syapse, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases, announced that they have entered into a strategic partnership with Genesis Research.
- This partnership will focus on conducting real-world evidence-based research that supports the development and launch of new and innovative treatments.
- As part of the
Read More
Intelerad Acquires PenRad Technologies
What You Should Know:
- Today, Intelerad, a leading global provider of enterprise medical imaging solutions, announced its acquisition of PenRad, a software provider for enhancing productivity for breast imaging and lung screening.
- The acquisition expands Intelerad’s product offerings for mammography and lung analytics, ensuring radiologists, technologists and other healthcare professionals can drive greater productivity and meet higher oncology screening demand, while improving patient
Read More
